| RS121917854 |
IHH
|
Health Risk |
Pathogenic |
Brachydactyly type A1, Brachydactyly type A1 |
| RS121917855 |
IHH
|
Health Risk |
Pathogenic |
Brachydactyly type A1, Brachydactyly type A1A |
| RS121917856 |
IHH
|
Health Risk |
Pathogenic |
Acrocapitofemoral dysplasia, Acrocapitofemoral dysplasia |
| RS121917857 |
IHH
|
Health Risk |
Pathogenic |
Acrocapitofemoral dysplasia, Acrocapitofemoral dysplasia |
| RS121917858 |
KERA
|
Health Risk |
Pathogenic |
Cornea plana 2, Cornea plana 2 |
| RS121917859 |
IHH
|
Health Risk |
Pathogenic |
Brachydactyly type A1, Brachydactyly type A1 |
| RS121917860 |
KERA
|
Health Risk |
Pathogenic |
Cornea plana 2, Cornea plana 2 |
| RS121917861 |
IHH
|
Health Risk |
Pathogenic |
Brachydactyly type A1, Brachydactyly type A1 |
| RS121917862 |
KERA
|
Health Risk |
Pathogenic |
Cornea plana 2, Cornea plana 2 |
| RS121917863 |
KERA
|
Health Risk |
Pathogenic |
Cornea plana 2, Cornea plana 2 |
| RS121917864 |
TLR2
|
Health Risk |
risk factor |
Leprosy, susceptibility to |
| RS121917865 |
NUP62
|
Health Risk |
Pathogenic |
Infantile bilateral striatal necrosis, Infantile bilateral striatal necrosis |
| RS121917867 |
MIP
|
Health Risk |
Pathogenic |
Cataract 15 multiple types, Cataract 15 multiple types |
| RS121917868 |
CPOX
|
Health Risk |
Pathogenic/Likely pathogenic |
Harderoporphyria, Hereditary coproporphyria |
| RS121917869 |
MIP
|
Health Risk |
Likely pathogenic |
Cataract 15 multiple types, Cataract 15 multiple types |
| RS121917870 |
CPOX
|
Health Risk |
Pathogenic |
Coproporphyria, Coproporphyria |
| RS121917871 |
CPOX
|
Health Risk |
Pathogenic |
Coproporphyria, Coproporphyria |
| RS121917872 |
CPOX
|
Health Risk |
Pathogenic |
Coproporphyria, Coproporphyria |
| RS121917873 |
CPOX
|
Health Risk |
Pathogenic |
Coproporphyria, Coproporphyria |
| RS121917874 |
CPOX
|
Health Risk |
Pathogenic |
COPROPORPHYRIA, DIGENIC |
| RS121917875 |
NHLRC1
|
Health Risk |
Pathogenic |
Myoclonic epilepsy of Lafora 2, Myoclonic epilepsy of Lafora 2 |
| RS121917876 |
NHLRC1
|
Health Risk |
Likely pathogenic |
Myoclonic epilepsy of Lafora 2, Lafora disease |
| RS121917878 |
SIX3
|
Health Risk |
Pathogenic |
Holoprosencephaly 2, Holoprosencephaly 2 |
| RS121917879 |
SIX3
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 2, Holoprosencephaly 2 |
| RS121917880 |
SIX3
|
Health Risk |
Pathogenic |
Holoprosencephaly 2, Holoprosencephaly 2 |
| RS121917882 |
SLC19A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotin-responsive basal ganglia disease, Inborn genetic diseases |
| RS121917883 |
GHSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature due to growth hormone secretagogue receptor deficiency, Inborn genetic diseases |
| RS121917884 |
SLC19A3
|
Health Risk |
Likely pathogenic |
Biotin-responsive basal ganglia disease, Inborn genetic diseases |
| RS121917888 |
HCCS
|
Health Risk |
Pathogenic |
Linear skin defects with multiple congenital anomalies 1, Linear skin defects with multiple congenital anomalies 1 |
| RS121917889 |
HCCS
|
Health Risk |
Likely pathogenic |
Linear skin defects with multiple congenital anomalies 1, HCCS-related disorder |
| RS121917892 |
UMPS
|
Health Risk |
Pathogenic |
Oroticaciduria, Oroticaciduria |
| RS121917893 |
NLGN3
|
Health Risk |
risk factor |
Autism, susceptibility to |
| RS121917894 |
RAG2
|
Health Risk |
Likely pathogenic |
Histiocytic medullary reticulosis, Severe combined immunodeficiency |
| RS121917895 |
RAG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Histiocytic medullary reticulosis, Severe combined immunodeficiency |
| RS121917896 |
RAG2
|
Health Risk |
Likely pathogenic |
Histiocytic medullary reticulosis, Recombinase activating gene 2 deficiency |
| RS121917897 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, B cell-negative |
| RS121917898 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS121917899 |
PQBP1
|
Health Risk |
Pathogenic |
Renpenning syndrome, Renpenning syndrome |
| RS121917900 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS121917901 |
ERCC6
|
Health Risk |
Pathogenic |
DE SANCTIS-CACCHIONE SYNDROME, Cockayne syndrome type 2 |
| RS121917902 |
ERCC6
|
Health Risk |
Pathogenic |
Cockayne syndrome type 2, DE SANCTIS-CACCHIONE SYNDROME |
| RS121917903 |
ERCC6
|
Health Risk |
Pathogenic |
UV-sensitive syndrome 1, Cockayne syndrome type 2 |
| RS121917904 |
ERCC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 1, ERCC6-related disorder |
| RS121917906 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS121917908 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS121917909 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917910 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Migraine |
| RS121917911 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917912 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS121917913 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917914 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS121917915 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917918 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Migraine |
| RS121917919 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917921 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917922 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917923 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS121917926 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917927 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Migraine |
| RS121917928 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917929 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917930 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121917931 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS121917935 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS121917936 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917937 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917938 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917939 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS121917941 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917943 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917945 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, See cases |
| RS121917949 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS121917950 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS121917951 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917952 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917953 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121917954 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121917955 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS121917957 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS121917959 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS121917960 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS121917961 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, See cases |
| RS121917963 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917964 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Migraine |
| RS121917965 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Migraine |
| RS121917966 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS121917967 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS121917969 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121917971 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Seizure |
| RS121917972 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS121917973 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS121917974 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS121917975 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS121917976 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Migraine |
| RS121917978 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS121917979 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 6B, Developmental and epileptic encephalopathy 6B |
| RS121917980 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS121917981 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS121917982 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS121917983 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |